WHO ICTRP trial
[11C]Erlotinib pharmacokinetics: an in vivo study using positron emission…
NL-OMON36826 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON36826 |
|---|---|
| Public title | [11C]Erlotinib pharmacokinetics: an in vivo study using positron emission tomography in non-small cell lung cancer patients with and without erlotinib therapy. |
| Scientific title | [11C]Erlotinib pharmacokinetics: an in vivo study using positron emission tomography in non-small cell lung cancer patients with and without erlotinib therapy. - [11C]erlotinib kinetics in NSCLC with and without erlotinib |
| Primary sponsor | Vrije Universiteit Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | Netherlands |
| Conditions | lung cancer non-small cell lung carcinoma;10038666;lung cancer;non-small cell lung carcinoma |
| Interventions | The procedure consists of a low dose CT scan, intravenous administration of [15O]H2O and 15-minutes [15O]H2O PET scan, followed by another low dose CT scan, intravenous administration of [11C]erlotinib and PET acquisition for about one hour… |
| Registration date | Feb 14, 2013 |
| Target size | 10 |
| Secondary IDs | 2012-004475-39;NL41138.029.12 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: